The current prices are delayed, login to your account for live prices
Login

Logo

Krishna Institute of Medical Sciences Share Price

KIMS
₹ 756.80
-₹7.30 (-0.96%)
1D
Last updated 25 May, 2026, 15:46 IST
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target

₹744.05
0.96% down in 1Day
₹769.95
1D LOW
1D HIGH
Open
769.95
High
769.95
Low
744.05
Prev. close
764.1

Circuit
L
H
₹611.3
₹916.9
52-week
L
H
₹575.8
₹798.4

Shareholder Returns

Share Price History

Mkt Cap Cr
30,572.6

P/E
126.29

P/B
13.6

ROE
10.74%

D/E
0.63

ROCE
7.99%

Div. Yield

EPS(TTM)
6.52
Turnover

EV/EBITDA
42.4

Net Margin
0%

Op. Margin
0%

ROA
3.12%

Quick Ratio
0

Curr. Ratio
2.03
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Step 1 of 5
Valuation
Overvalued
Step 3 of 5
Earnings
Neutral

Financials

Full statement

Consolidated - Yearly
All values are in INR Crore
Consolidated
Annually
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
1
Neutral
6
Bullish
1
Neutral
Indicator
Value
Verdict

RSI (14)
61.12
Neutral

ATR (14)
33.49
Neutral

STOCH(9,6)
65.4
Neutral

STOCH RSI (14)
34.53
Neutral

ADX(9)
38.04
Bearish

UO(9)
53.45
Neutral

ROC(12)
9.11
Bullish

WillR(14)
-22.25
Neutral
Period
Simple value
Exponential vaue

5D
749.39
757.82

10D
758.6
748.22

20D
719.51
728.22

50D
681.38
698.17

100D
664.49
685.93
About Krishna Institute of Medical Sciences
Krishna Institute of Medical Sciences logo
NSE Symbol
KIMS
BSE Symbol
BSE: 543308
ISIN
INE967H01025
Sector Market Cap
₹ 30,572.6 Cr

Krishna Institute of Medical Sciences, or KIMS, is a corporate healthcare group, with hospitals in Telangana, Andhra Pradesh and Maharashtra. It provides multi-disciplinary integrated healthcare services with a focus on tertiary and quaternary healthcare.

KIMS was initially established as Jagjit Singh and Sons Private Limited in 1973 in Mumbai. Later, in 2004, the company's name was changed to Krishna Institute of Medical Sciences Private Limited. Until 2003, Jagjit Singh and some of his family members solely owned, managed and controlled the company. In February 2003, certain promoters of the company, including Dr Bhaskar Rao Bollineni and Krishnaiah Bollineni, along with other individuals and entities, acquired the entire equity share capital of the company.

KIMS began its journey in Nellore, Andhra Pradesh, establishing its oldest hospital with a capacity of about 200 beds. Two years later, in 2002, the group expanded its presence by inaugurating another hospital in Rajahmundry, Andhra Pradesh. KIMS hospital, located in Secunderabad, was established in 2004 and has a capacity of 1,000 beds, as per a CRISIL Report.

The main hospitals in Secunderabad and Rajahmundry have received accreditation from the National Accreditation Board for Hospitals and Healthcare Providers India (NABH).

Over the years, the group ventured into various cities in Andhra Pradesh and Maharashtra, apart from Telangana. In 2021, KIMS acquired a stake in Hyderabad-based Sunshine Hospitals. The following year, in 2022, it expanded its footprint by signing an MoU with Dr Raj Nagarkar, a surgical oncologist in western Maharashtra, to establish KIMS Manavata Hospital, a multi-specialty facility in Nashik with a total bed capacity of 325. KIMS also acquired a majority stake in Kingsway Hospitals in Nagpur in 2022. KIMS went public in 2021 with its initial public offering (IPO), transitioning into a public company.

The market capitalisation of Krishna Institute of Medical Sciences Limited is over ₹18,300 crore as of February 28, 2024. KIMS share price has gained over 70% in the last one year.

Business Operations

KIMS manages 12 multispecialty hospitals, providing a wide array of healthcare services across more than 40 specialities and super specialities. These include cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and childcare.

The Sunshine Hospitals which came into the hands of KIMS generated a revenue contribution of 19%. The KIMS SUNSHINE will be shifted soon to the company’s premises which will add 300 new beds. FY 2023 FY marked the group's foray into Maharashtra at important centres like Nagpur and Nashik through strategic alliances. The Nagpur unit brought another 330+ beds.

The company is all set to enter Karnataka in the ensuing year with a 250-bed hospital in the heart of Bengaluru. There are immediate plans to expand its wings to Thane, Mumbai in the next year. All these initiatives will lead to a doubling of its capacity to 8,000 beds in the next 2-3 years spanning across the states of Telangana, AP, Maharashtra and Karnataka.

Financial Highlights

– Krishna Institute of Medical Sciences Limited's revenue for the financial year 2023 stood at ₹2,198 crore, up 33% compared to ₹1,651 crore in FY22. – The net profit after tax for the financial year 2022-23 was ₹367 crore compared to ₹344 crore during the previous year. – In FY23, the earnings before interest, tax, depreciation and amortisation (EBITDA) increased to ₹577 crore from the previous year's ₹512 crore. – The company's earnings per share (EPS) stood at ₹42.03 in FY23 compared to ₹41.88 in the previous financial year.

Krishna Institute of Medical Sciences Share Price Today

As of 25 May 2026, Krishna Institute of Medical Sciences share price is ₹756.80. The stock opened at ₹769.95, compared to its previous close of ₹764.10. During today's trading session, Krishna Institute of Medical Sciences share price moved in the range of ₹744.05 to ₹769.95, with an average price of ₹757.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹744.05 and a high of ₹769.95. On the performance front, Krishna Institute of Medical Sciences share price has increased by 14.03% over the last six months and is up 14.29% on a year-on-year basis.

The market capitalization of Krishna Institute of Medical Sciences is ₹30,573 Crs, with a P/E ratio of 126.3 and a dividend yield of 0.00%.

Frequently Asked Questions